Since 1976
Ramco Laboratories, Inc.
Ramco Laboratories, Inc., formed in 1976, manufactures, assembles, and markets proprietary medical diagnostic test kits.
Ramco sells to physician groups, hospitals, and reference laboratories in the U.S. and to distributors and directly to customers in international markets.
Ramco is a privately held company founded by Dr. Clarence Alfrey an MD, PhD. Dr. Alfrey is a leading hematologist in the Texas Medical Center, a researcher for NASA, on staff at the Baylor College of Medicine, the retired medical director of the Gulf Coast Regional Blood Center, and a former President of the Harris County Medical Society.
One of the highlights of the exclusive Ramco portfolio is the "Cand Tec" test, for which Ramco is the exclusive producer worldwide. The "Cand Tec" test is a latex agglutination test for detecting antigen associated with systemic Candidiasis. Other highlights are the 30 years expertise for Ferritin determinations (EIA and RIA) or the EIA microplate assay for quantifying serum transferrin receptor ("Transferrin Receptor").
BÜHLMANN represents Ramco Laboratories in Switzerland and in Austria.
List of actually requested Ramco Products in Switzerland and Austria.more
Visit Ramco Laboratories, Inc. Homepage.
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.
The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve more
New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.
EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma. more
BÜHLMANN innovations and news at the JIB
At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |